Cipta Sarana Medika Tbk. vs Puradelta Lestari Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T, 40.24M 24h volume). The key difference: Puradelta Lestari Tbk. is far larger — about 41.7× Cipta Sarana Medika Tbk.'s market cap, and Puradelta Lestari Tbk. is more actively traded (40.24M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | DMAS | |
|---|---|---|
Market Cap | 158.12B | 6.6T |
Volume | 8.21M | 40.24M |
Lot | 82.15K | 402.39K |
Turnover | 515.2M | 5.52B |
Average Price | 62.72 | 137.3 |
Value | 515.2M | 5.52B |
Indicative Equilibrium Price | 63 | 137 |
Indicative Equilibrium Volume | 1.33K | 9.27K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Read more on DMAS →